CODIS: Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19

Sponsor
Ludwig Boltzmann Institute for Digital Health and Prevention (Other)
Overall Status
Completed
CT.gov ID
NCT04501432
Collaborator
Institute of Sports Medicine, Prevention and Rehabilitation, Salzburg, Austria (Other)
27
1
3.4
8.1

Study Details

Study Description

Brief Summary

The current Coronavirus Disease 2019 (COVID-19) pandemic has resulted in extraordinary public health orders of social distancing and self-isolation, leading to widespread disruption and discontinuation of cardiac rehabilitation programmes and other social opportunities for cardiovascular disease (CVD) patients to exercise. In Austria, the government initiated drastic public health measures (national lockdown) on March 16, 2020, leading to closure of all outpatient cardiac rehabilitation facilities and restriction of inpatient rehabilitation to patients with urgent medical indications only.

This study aims to explore the impact of COVID-19-related national lockdown and public health restrictions on cardiac rehabilitation patients, with respect to maintenance of physical activity for secondary CVD prevention.

The study poses three research questions, which will be addressed in a mixed-methods study with sequential quantitative-qualitative (QUANT-QUAL) design:

  1. What was the impact of the COVID-19-related lockdown on patients' physical activity and physical fitness levels? (QUANT stage)

  2. What was the patient experience of the closure of group-based cardiac rehabilitation training due to COVID-19 public health restrictions? (QUAL stage)

  3. Which insights and learning points may be drawn from patients' experiences during COVID-19 public health restrictions with respect to the provision of home-based digital support for physical activity? (QUAL stage)

The study will recruit a cohort of up to 40 cardiac rehabilitation patients from one outpatient cardiac rehabilitation centre in Salzburg, Austria, whose rehabilitation programme was interrupted by COVID-19 public health orders, including "lockdown".

Patients will undergo re-assessment of physical fitness in cycle ergometry test and re-assessment of cardiovascular risk profile. This will be compared with patients' most recent available test results from before the COVID-19 lockdown (i.e. prior to mid-March 2020) from patient records. Additionally, patients will take part in a semi-structured qualitative interview in which they will be invited to reflect on their personal experiences during the COVID-19 lockdown and thereafter.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention

Study Design

Study Type:
Observational
Actual Enrollment :
27 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Cardiac Rehabilitation and Ongoing Physical Activity During the Coronavirus Disease (COVID-19) Pandemic: An Exploratory Mixed-Methods Study
Actual Study Start Date :
Jul 14, 2020
Actual Primary Completion Date :
Oct 24, 2020
Actual Study Completion Date :
Oct 24, 2020

Arms and Interventions

Arm Intervention/Treatment
Cardiac Rehabilitation

Participants will be recruited from a group of patients who regularly attended group-based cardiac rehabilitation exercise training at the study site until COVID-19 restrictions (national lockdown) came into force on 16th March 2020.

Other: No intervention
This study does not include an intervention

Outcome Measures

Primary Outcome Measures

  1. Work load (W) [up to 12 months]

    Maximal work load (W) achieved in cycle ergometry test

  2. Work load % of predicted value [up to 12 months]

    Maximal work load (W) achieved in cycle ergometry test expressed as percentage of predicted value

  3. Heart rate (bpm) [up to 12 months]

    Maximal heart rate (bpm) during cycle ergometry test

  4. Framingham Recurrent Coronary Heart Disease risk score [up to 12 months]

    Range 1% to 29%, higher percentage indicating worse risk estimate

Secondary Outcome Measures

  1. Metabolic Equivalent (MET) minutes / week [up to 12 months]

    MET-minutes/week calculated from patient self-report of physical activity (International Physical Activity Questionnaire, IPAQ, 7 day version)

  2. Patient Experience [5 months]

    Semi-structured qualitative interview

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Adults (18 years and over)

  • Cardiovascular disease (CVD)

  • Currently enrolled in outpatient cardiac rehabilitation training at the study site

  • Informed consent

Exclusion Criteria:
  • Contraindications for cardiopulmonary exercise testing

  • Pathologies limiting exercise performance

  • Pregnancy or breastfeeding

  • Limited German language

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institute of Sports Medicine, Prevention and Rehabilitation Salzburg Austria 5020

Sponsors and Collaborators

  • Ludwig Boltzmann Institute for Digital Health and Prevention
  • Institute of Sports Medicine, Prevention and Rehabilitation, Salzburg, Austria

Investigators

  • Principal Investigator: Stefan T Kulnik, PhD MRes, Ludwig Boltzmann Institute for Digital Health and Prevention

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ludwig Boltzmann Institute for Digital Health and Prevention
ClinicalTrials.gov Identifier:
NCT04501432
Other Study ID Numbers:
  • 23_CODIS
First Posted:
Aug 6, 2020
Last Update Posted:
Jan 6, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ludwig Boltzmann Institute for Digital Health and Prevention
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 6, 2022